Product Information
for Healthcare Professionals

We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases. We are investing billions in Research and Development (R&D), which includes the discovery and development of new medicines.

OPDYTA® (Nivolumab)

YERVOI® (Ipilimumab)

ROJUZDA® (Luspatercept)


ONC-IN-2100116 valid till 7 Oct 2022